UBS(Lux)E.F.-Biotech(USD)P a.USD
MVD-Fonds Rating | EDA |
---|---|
![]() ![]() ![]() ![]() ![]() ![]() | 74 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS Fund M. (LU)
NAV: 758,68 USD am 14.04.2021

Kennzahlen UBS(Lux)E.F.-Biotech(USD)P a.USD
1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
Performance | -3,10% | -0,34% | +18,77% | +34,94% | +57,22% | +260,59% | +658,68% |
Volatilität | +23,36% | +22,90% | +24,27% | +25,84% | +24,24% | +25,41% | +27,86% |
Sharpe Ratio | -1,34 | -0,01 | +0,80 | +0,43 | +0,41 | +0,56 | +0,33 |
Bester Monat | - | +10,70% | +14,55% | +14,95% | +14,95% | +15,66% | +41,13% |
Schl. Monat | - | -4,94% | -4,94% | -13,55% | -13,55% | -21,18% | -28,27% |
Max. Verlust | -5,67% | -14,33% | -15,52% | -25,18% | -25,72% | -40,97% | -75,23% |
Monatsperformance UBS(Lux)E.F.-Biotech(USD)P a.USD
2006 | 2005 | 2004 | 2003 | 2002 | |
Januar | +3,38% | -5,75% | +6,35% | -3,18% | -13,60% |
Februar | +4,40% | -6,14% | +0,73% | -1,77% | -6,28% |
März | -2,11% | -6,85% | +0,68% | +4,81% | +3,21% |
April | -6,24% | -0,67% | +2,96% | +7,49% | -14,39% |
Mai | -6,02% | +2,85% | -3,19% | +15,57% | -10,11% |
Juni | +0,32% | +2,04% | -1,79% | -3,30% | -13,84% |
Juli | -1,16% | +12,27% | -10,15% | +11,62% | +2,73% |
August | +2,34% | +2,28% | -0,06% | +0,97% | -5,61% |
September | +1,01% | +0,31% | +4,18% | -3,32% | -5,36% |
Oktober | +8,17% | -5,00% | -3,94% | -0,52% | +8,14% |
November | -0,45% | +5,46% | +2,77% | +0,17% | +7,57% |
Dezember | -2,90% | +3,82% | +7,94% | +3,77% | -11,60% |
Gesamt | -0,22% | +2,92% | +5,25% | +34,92% | -47,71% |